Tectonic Therapeutic, Inc. (TECX) › Operating IncomeTectonic Therapeutic, Inc. (TECX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$18.39M2018: -$46.24M2019: -$75.81M2020: -$120.23M2021: -$118.84M2022: -$105.43M2023: -$44.65M2024: -$58.02M2025: -$84.04M-$84.04M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$84.04M-44.9%2024-$58.02M-29.9%2023-$44.65M+57.7%2022-$105.43M+11.3%2021-$118.84M+1.2%2020-$120.23M-58.6%2019-$75.81M-63.9%2018-$46.24M-151.5%2017-$18.39M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share